SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-23-009381
Filing Date
2023-03-29
Accepted
2023-03-29 07:30:53
Documents
87
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1882944
2 ex3-3.htm EX-3.3 108019
3 ex21.htm EX-21 2576
4 ex23-1.htm EX-23.1 3496
5 ex31-1.htm EX-31.1 16315
6 ex31-2.htm EX-31.2 16713
7 ex32.htm EX-32 13155
  Complete submission text file 0001493152-23-009381.txt   8483888

Data Files

Seq Description Document Type Size
8 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abeo-20221231.xsd EX-101.SCH 54223
9 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abeo-20221231_cal.xml EX-101.CAL 85025
10 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abeo-20221231_def.xml EX-101.DEF 259624
11 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abeo-20221231_lab.xml EX-101.LAB 492837
12 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abeo-20221231_pre.xml EX-101.PRE 397444
81 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1272016
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15771 | Film No.: 23771763
SIC: 2834 Pharmaceutical Preparations